Ovid Therapeutics, Inc. (OVID)
2.255
-0.04
(-1.96%)
USD |
NASDAQ |
Apr 07, 11:46
Ovid Therapeutics SG&A Expense (TTM) : 24.11M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| PTC Therapeutics, Inc. | 347.14M |
| CytomX Therapeutics, Inc. | 29.84M |
| Artelo Biosciences, Inc. | 5.981M |
| Eton Pharmaceuticals, Inc. | 35.82M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |